NCT00422058 - The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes | Biotech Hunter

Enrollment

564

Participants

Timeline

Start Date

January 10, 2007

Primary Completion Date

September 13, 2007

Study Completion Date

April 30, 2009

Conditions

Metabolism and Nutrition DisorderObesity

Interventions

DRUG

liraglutide

Injected s.c. (under the skin) once daily

DRUG

orlistat

120 mg capsule. Administered thrice daily

DRUG

placebo

Injected s.c. (under the skin) once daily

Trial Locations (19)

1958

Novo Nordisk Investigational Site, Frederiksberg C

2650

Novo Nordisk Investigational Site, Edegem

Novo Nordisk Investigational Site, Hvidovre

8000

Novo Nordisk Investigational Site, Århus C

28006

Novo Nordisk Investigational Site, Madrid

28007

Novo Nordisk Investigational Site, Madrid

31008

Novo Nordisk Investigational Site, Pamplona

70210

Novo Nordisk Investigational Site, Kuopio

90220

Novo Nordisk Investigational Site, Oulu

116 94

Novo Nordisk Investigational Site, Prague

128 08

Novo Nordisk Investigational Site, Prague

00270

Novo Nordisk Investigational Site, Helsinki

1311RL

Novo Nordisk Investigational Site, Almere Stad

08022

Novo Nordisk Investigational Site, Barcelona

205 02

Novo Nordisk Investigational Site, Malmo

141 86

Novo Nordisk Investigational Site, Stockholm

G322ER

Novo Nordisk Investigational Site, Glasgow

LU4 0DZ

Novo Nordisk Investigational Site, Luton

NR4 7TJ

Novo Nordisk Investigational Site, Norwich